HLB Co., Ltd. (KOSDAQ:028300)
South Korea · Delayed Price · Currency is KRW 44,400
-1,250 (-2.74%)
Oct 12, 2026, 3:30 PM KST
HLB Co., Ltd. Market Cap
HLB Co., Ltd. has a market cap or net worth of 5.9 trillion as of October 12, 2026. It is the 3,964th most valuable company in the world and the 97th biggest in South Korea. Its market cap has increased by 21.59% in one year.
Market Cap
5.90T
Enterprise Value
6.34T
Revenue
97.47B
Global Rank
Country Rank
#97 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since December 24, 2008, HLB Co., Ltd.'s market cap has increased from 13.46B to 5.90T, an increase of 43,754.61%. That is a compound annual growth rate of 40.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 12, 2026 | 5.90T | -11.71% |
| Dec 30, 2025 | 6.69T | -30.26% |
| Dec 30, 2024 | 9.59T | 46.53% |
| Dec 28, 2023 | 6.54T | 98.02% |
| Dec 29, 2022 | 3.30T | -10.84% |
| Dec 30, 2021 | 3.71T | -24.18% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ALTEOGEN | 16.78T |
| Samsung Epis Holdings | 8.46T |
| SK Biopharmaceuticals | 5.69T |
| SK bioscience | 2.87T |
| LigaChem Biosciences | 2.70T |
| ABL Bio | 2.69T |
| OliX Pharmaceuticals | 2.67T |
| Voronoi | 2.51T |